Not all patients with CLL demand therapy. Irrespective of all modern improvements, the iwCLL continue to endorses watchful observation for sufferers with asymptomatic disease.86 This advice relies on no less than two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Anda pasti harus memikirkan https://ermaf207bkt5.blue-blogs.com/profile